THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Stent maker commits $40m to post-op kits

Goal is to get patients to take blood thinners

Boston Scientific's information guide for its Taxus stent. Boston Scientific's information guide for its Taxus stent.
By Diedtra Henderson
Globe Staff / April 2, 2007

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size – +

WASHINGTON -- Boston Scientific Corp. plans to spend up to $40 million on a campaign to educate patients who receive the company's heart stents about the importance of sticking with the blood-thinning drugs they are prescribed after surgery. (Full article: 540 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $4.95 1 article
  • $9.95 4 articles
  • $25.95 Monthly